IMMUTEP LIMITED — Director's Dealing 2024

Dec 9, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	IMMUTEP LIMITED (ASX: IMM)
ABN	90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Russell John Howard
Date of last notice	23 November 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Regulus Star Pty Ltd (Russell Howard)
Date of change	6 December 2024
No. of securities held prior to change	1. 1,113,207 Fully Paid Ordinary Shares 2. 404,770 Director Performance Rights
Class	1. Fully Paid Ordinary Shares (ASX: IMM) 2. Performance Rights (ASX: IMMAM)
Number acquired	304,770 Fully Paid Ordinary Shares (ASX: IMM)
Number disposed	304,770 Director Performance Rights (ASX: IMMAM)

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil for the issue of 304,770 shares. No amount is payable upon exercise of the 2nd and 3rd tranche of Director Performance Rights which were approved by shareholders at the 2021 AGM and for the 1stand 2nd tranche of additional Performance Rights which were approved by the shareholders at the 2023 AGM.
No. of securities held after change	1. 1,417,977 Fully Paid Ordinary Shares 2. 100,000 Director Performance Rights
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	226,414 shares were issued upon vesting and exercising of 2ndand 3rd tranche of Performance Rights out of the 339,621 Director Performance Rights which were issued in lieu of additional cash to compensate Dr Howard for his additional responsibilities as Chairman of the Company in accordance with the Shareholders approval obtained at the 2021 AGM. 78,356 shares were issued upon vesting and exercising of 1stand 2ndtranche of Performance Rights out of the 178,356 additional Performance Rights were issued to Dr Howard in accordance with shareholder approval obtained at the 2023 AGM.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N.A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3